Argenx
ARGX
#534
Rank
$38.14 B
Marketcap
$623.82
Share price
-0.35%
Change (1 day)
76.16%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : $4.26 Billion USD

According to Argenx 's latest financial reports the company has $4.26 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$$2.81 B11.03%
2021-12-31$$2.53 B23.08%
2020-12-31$$2.05 B55.72%
2019-12-31$$1.32 B87.68%
2018-12-31$$0.70 B41.9%
2017-12-31$$0.49 B608.23%
2016-12-31$$70.1 M57.32%
2015-12-31$$44.56 M-39.83%
2014-12-31$$74.06 M78.94%
2013-12-31$$41.39 M87.92%
2012-12-31$$22.02 M-39.2%
2011-12-31$$36.23 M166.19%
2010-12-31$$13.61 M